help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 26, 2003
Endocrinology, doi:10.1210/en.2003-0225
A more recent version of this article appeared on October 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/10/4410    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mellor, S. L
Right arrow Articles by Risbridger, G. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mellor, S. L
Right arrow Articles by Risbridger, G. P

Submitted on February 19, 2003
Accepted on June 18, 2003

Activin {beta}C subunit heterodimers provide a new mechanism of regulating activin levels in the prostate

Sally L Mellor1, Emma MA Ball1, Anne E O'Connor1, Jean-François Ethier1, Mark Cranfield1, Jacqueline F Schmitt1, David J Phillips1, Nigel P Groome1, and Gail P Risbridger1*

1 Monash Institute of Reproduction and Development, Monash University, Melbourne, Victoria, Australia (SLM, EMAB, AEO'C, JFS, DJP, GPR) Prince Henry's Institute of Medical Research, PO Box 5152, Clayton, Victoria 3168, Australia (J-FE); School of Biological and Molecular Sciences, Oxford Brookes University, Headington, Oxford, United Kingdom (MC, NPG)

* To whom correspondence should be addressed. E-mail: gail.risbridger{at}med.monash.edu.au.

Activins are formed by dimerization of {beta} subunits and, as members of the TGF-{beta} superfamily, have diverse roles as potent growth and differentiation factors. Since the biological function of the activin C homodimer ({beta}C-{beta}C) is unknown, we sought to compare activin A ({beta}A-{beta}A), B({beta}B-{beta}B) and C homodimer bioactivity and to investigate the consequences of activin {beta}C subunit overexpression in prostate tumor cells. Exogenous activin A and B homodimers inhibited cell growth and activated activin-responsive promoters. In contrast, the activin C homodimer was unable to elicit these responses. We previously showed that the activin {beta}C subunit heterodimerised with activin {beta}A in vitro to form activin AC. Therefore, we hypothesize that the activin {beta}C subunit regulates the levels of bioactive activin A by the formation of activin AC heterodimers. To test this hypothesis we measured activin AC heterodimer production using a novel specific two-site enzyme linked immunosorbent assay (ELISA) that we developed for this purpose. In the PC3 human prostate tumor cell line, activin {beta}C subunit overexpression increased activin AC heterodimer levels, concomitantly reduced activin A levels and decreased activin signaling. Overall, these data are consistent with a role for the activin {beta}C subunit as a regulatory mechanism to reduce activin A secretion via intracellular heterodimerization.


Key words: Activin {beta}C subunit • activin AC • activin A • prostate • ELISA







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society